This ETF Lets You Benefit From Higher Oil Prices Without the Comedown — Positive

MLPA   24/7 Wall Street — April 03, 2026

When geopolitical shocks send oil prices lurching higher, most energy investors reach for crude producers.

image for news This ETF Lets You Benefit From Higher Oil Prices Without the Comedown

Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report? — Positive

ELV   Zacks Investment Research — April 03, 2026

Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report? — Positive

REGN   Zacks Investment Research — April 03, 2026

Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Will ATI (ATI) Beat Estimates Again in Its Next Earnings Report? — Positive

ATI   Zacks Investment Research — April 03, 2026

ATI (ATI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will ATI (ATI) Beat Estimates Again in Its Next Earnings Report?

Will Polaris Inc (PII) Beat Estimates Again in Its Next Earnings Report? — Positive

PII   Zacks Investment Research — April 03, 2026

Polaris Inc (PII) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Polaris Inc (PII) Beat Estimates Again in Its Next Earnings Report?

Why KeyCorp (KEY) Could Beat Earnings Estimates Again — Positive

KEY   Zacks Investment Research — April 03, 2026

KeyCorp (KEY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why KeyCorp (KEY) Could Beat Earnings Estimates Again

Will Las Vegas Sands (LVS) Beat Estimates Again in Its Next Earnings Report? — Positive

LVS   Zacks Investment Research — April 03, 2026

Las Vegas Sands (LVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Las Vegas Sands (LVS) Beat Estimates Again in Its Next Earnings Report?

Will The PNC Financial Services Group (PNC) Beat Estimates Again in Its Next Earnings Report? — Positive

PNC   Zacks Investment Research — April 03, 2026

The PNC Financial Services Group (PNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will The PNC Financial Services Group (PNC) Beat Estimates Again in Its Next Earnings Report?

Will Virtu Financial (VIRT) Beat Estimates Again in Its Next Earnings Report? — Positive

VIRT   Zacks Investment Research — April 03, 2026

Virtu Financial (VIRT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Virtu Financial (VIRT) Beat Estimates Again in Its Next Earnings Report?

Will Constellation Brands (STZ) Beat Estimates Again in Its Next Earnings Report? — Positive

STZ   Zacks Investment Research — April 03, 2026

Constellation Brands (STZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Constellation Brands (STZ) Beat Estimates Again in Its Next Earnings Report?

Will Matador (MTDR) Beat Estimates Again in Its Next Earnings Report? — Positive

MTDR   Zacks Investment Research — April 03, 2026

Matador (MTDR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Matador (MTDR) Beat Estimates Again in Its Next Earnings Report?

Will HF Sinclair (DINO) Beat Estimates Again in Its Next Earnings Report? — Positive

DINO   Zacks Investment Research — April 03, 2026

HF Sinclair (DINO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will HF Sinclair (DINO) Beat Estimates Again in Its Next Earnings Report?

Will U.S. Bancorp (USB) Beat Estimates Again in Its Next Earnings Report? — Positive

USB   Zacks Investment Research — April 03, 2026

U.S. Bancorp (USB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will U.S. Bancorp (USB) Beat Estimates Again in Its Next Earnings Report?

Will CME (CME) Beat Estimates Again in Its Next Earnings Report? — Positive

CME   Zacks Investment Research — April 03, 2026

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? — Positive

UTHR   Zacks Investment Research — April 03, 2026

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

Will Northern Trust (NTRS) Beat Estimates Again in Its Next Earnings Report? — Positive

NTRS   Zacks Investment Research — April 03, 2026

Northern Trust (NTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Northern Trust (NTRS) Beat Estimates Again in Its Next Earnings Report?

BENSALEM, Pa., April 03, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

image for news DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors that a securities fraud class action lawsuit has been filed against Aldeyra Therapeutics, Inc., (“Aldeyra” or the "Company") (NASDAQ: ALDX) on behalf of investors that bought securities between November 3, 2023 and March 16, 2026, inclusive (the “Class Period”). Investors have until May 29, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

image for news Shareholders who lost money in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Should Contact Wolf Haldenstein Immediately

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BlackRock TCP (TCPC) To Contact Him Directly To Discuss Their Options

image for news BLACKROCK TCP DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds BlackRock TCP Investors with Large Losses to Contact the Firm Before April 6th

60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know — Positive

SXTP   Zacks Investment Research — April 03, 2026

60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news 60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know